HSBC Forecasts Strong Price Appreciation for Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical (NASDAQ:ISRG) had its target price lifted by equities researchers at HSBC from $644.00 to $653.00 in a research note issued on Monday,MarketScreener reports. The firm currently has a “buy” rating on the medical equipment provider’s stock. HSBC’s target price would suggest a potential upside of 24.37% from the company’s current price.

Several other brokerages have also recently commented on ISRG. Mizuho set a $575.00 target price on Intuitive Surgical in a report on Wednesday, October 22nd. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, January 17th. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research note on Friday, January 23rd. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Finally, Piper Sandler reissued an “overweight” rating and issued a $620.00 price target (up previously from $610.00) on shares of Intuitive Surgical in a report on Friday. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $620.41.

Intuitive Surgical Trading Down 0.7%

Shares of Intuitive Surgical stock opened at $525.04 on Monday. The stock has a market capitalization of $188.21 billion, a price-to-earnings ratio of 66.55, a P/E/G ratio of 4.12 and a beta of 1.67. The firm’s 50-day moving average price is $561.53 and its two-hundred day moving average price is $511.67. Intuitive Surgical has a 1-year low of $425.00 and a 1-year high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the previous year, the business earned $2.21 EPS. Intuitive Surgical’s revenue was up 18.8% compared to the same quarter last year. As a group, equities research analysts predict that Intuitive Surgical will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares in the company, valued at approximately $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Craig H. Barratt sold 750 shares of the firm’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $435,000.00. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 48,027 shares of company stock worth $27,402,696. Corporate insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

Large investors have recently modified their holdings of the business. Vanguard Group Inc. grew its stake in Intuitive Surgical by 0.8% in the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after purchasing an additional 263,828 shares in the last quarter. State Street Corp boosted its holdings in shares of Intuitive Surgical by 1.2% in the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after buying an additional 182,871 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Intuitive Surgical by 1.4% in the second quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after buying an additional 109,904 shares in the last quarter. Capital World Investors increased its holdings in Intuitive Surgical by 1.5% during the third quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock worth $3,456,223,000 after buying an additional 116,034 shares during the last quarter. Finally, Norges Bank bought a new stake in Intuitive Surgical during the second quarter worth $2,569,260,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: TD Cowen initiated coverage with a Buy and a $660 target, citing the da Vinci 5 rollout and secular procedure growth as catalysts that could drive multi-year revenue and margin upside. TD Cowen initiates coverage
• Positive Sentiment: TD Cowen / TipRanks coverage note expands on the same thesis, highlighting da Vinci 5 rollout execution and secular procedure growth as underpinning a $660 target. TipRanks: TD Cowen Buy Rating
• Positive Sentiment: The FDA granted 510(k) clearance for the da Vinci 5 in select cardiac procedures, expanding the platform into more minimally invasive heart surgeries — a direct product/regulatory win that can support procedure growth and long-term consumable revenue. da Vinci 5 FDA clearance
• Positive Sentiment: HSBC raised its price target to $653 and maintained a Buy, reinforcing bullish analyst sentiment and implying meaningful upside from current levels. HSBC raises PT to $653
• Positive Sentiment: Barclays reiterated its Buy rating, another vote of confidence from the sell-side that supports investor sentiment. Barclays remains Buy
• Positive Sentiment: American Banking News reports a raised price target to $615, adding to the cluster of higher analyst targets that can support upside expectations. Price target raised to $615
• Neutral Sentiment: Interest in ISRG is high among retail/institutional investors (searches up), which can increase short-term volatility but does not by itself change fundamentals. Investors heavily search ISRG
• Negative Sentiment: Zacks highlights rising competitive pressure in China — slower tenders, local favoritism and pricing pressure — which could weigh on growth and margins in a key market if trends accelerate. China competition headwinds
• Negative Sentiment: Robert W. Baird trimmed its price target to $645 — a modest downgrade that could temper upside expectations even though the target remains above current levels. Baird cuts PT to $645

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.